NCT00142870View on ClinicalTrials.gov

Effectiveness of Bupropion in Treating Marijuana Dependent Individuals

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions
Marijuana AbuseSubstance-Related Disorders
Interventions
DRUG

Bupropion

150 mg, twice a day

Trial Locations (1)

02478 9106

McLean Hospital, Dept. of Psychiatry, Belmont

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00142870 - Effectiveness of Bupropion in Treating Marijuana Dependent Individuals | Biotech Hunter | Biotech Hunter